Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review.

Langendam MW, Tiemersma EW, van der Werf MJ, Sandgren A.

PLoS One 2013;8(1):e53599.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/?term=Adverse+Events+in+Healthy+Individuals+and+MDR-TB+Contacts+Treated+with+Anti-Tuberculosis+Drugs+Potentially+Effective+for+Preventing+Development+of+MDR-TB%3A+A+Systematic+Review

Search in knowledge base

Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Indonesia
Kazakhstan
Kenya
Kyrgyzstan
Namibia
Nigeria
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Key Technical Assistance Intervention Pathways

Improved scientific methods and models to end TB

Stronger health systems, data driven planning

Zero TB related stigma

Optimized digital health solutions along the patient pathway

TB vaccine access strategies

New Diagnostics and Laboratory Network Design

New drugs & treatment regimens

Diagnosis & treatment of LTBI

People-Centred Framework for TB Programming: Development of Optimized National Strategic Plans

Childhood TB – KNCV Benchmarking Tool for TB in Children and Adolescents

Current Projects

ASCENT
ASTTIE
ETBE Project
Evaluation of SeroSelectTB
GeneXpert MTB/RIF Test
iDEFEAT TB Project
IMPAACT4C19
IMPAACT4TB
LIFT-TB 
No More Pandemics
PANGenS
People-Centered Framework for TB Programming (PCF)
Triage Test for All Oral DR TB Regimen (TriAD)
SMART4TB
The Global Fund to Fight AIDS, Tuberculosis and Malaria

Completed Projects

Challenge TB
Development of a comprehensive Digital Training Package
E-detect
Improved TB/HIV Prevention & Care – Building Models for the Future Project
PAVIA
PODTEC
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania
TREATS

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

KNCV’s Technical Assistance package

Annual Report 2023 

Annual Report 2023 at a glance

Annual Reports from previous years

Strategic Plan 2020

KNCV’s SOS Stoolbox

KNCV Benchmarking Tool for TB in Children and Adolescents

KNCV’s Self-assessment checklist and planning tool – KNCV – Tuberculosefonds

KNCV’s People Centered Framework (Handbook, Dashboard, Toolkit)

KNCV’s Success Stories from IMPAACT4TB – 4 countries

KNCV’s Success Stories from IMPAACT4TB – Malawi

TB Stigma Measurement Guidance

From the Inside Out – Dealing with TB-related Self-stigma and Shame

Allies Approach – The KNCV Stigma Reduction Toolbox

KNCV 2-pager TB Photovoices